A study has found that the ‘antibiotic resistance (AMR)’ of hospitalized patients due to the COVID-19 pandemic is much higher than before. Antibiotic resistance increased during the pandemic in both COVID-19 positive as well as negative patients.
Antibiotic resistance refers to the ability of bacteria to reproduce without being affected by specific or many types of antibiotics. In other words, there is a problem that antibiotic efficacy is not shown because resistance develops due to the abuse of antibiotics, etc.
Dr. Karri Bauer of the US pharmaceutical company Merck (MSD) and Dr. Becton Dickinson and Dr. Vikas Gupta of medical device companies reported that drug-resistant infections are significantly higher in hospital outbreaks during the pandemic. It was published on the American Association for the Advancement of Science (AAAS) website.
According to the study analysis, the rate of antibiotic resistance (AMR) was 3.54 per 100 hospitalizations before the pandemic and 3.47 per 100 hospitalizations during the pandemic. However, patients who tested positive or negative for COVID-19 had higher AMR levels than pre-pandemic patients, increasing to 4.92 and 4.11 cases per 100 hospitalizations, respectively.
For hospital-related infections, the AMR rate was 0.77 cases per 100 hospitalizations before the pandemic and 0.86 cases during the epidemic period, with corona patients the highest at 2.19 cases per 100 hospitalizations.
The results of this study concluded that it is important to closely monitor the effect of COVID-19 on antimicrobial resistance. Of particular concern is the increasing antibiotic resistance among all coronavirus-tested patients, with the rate of resistance during the pandemic even higher.
The study was conducted on all adults 18 years of age and older who were hospitalized in 271 US hospitals, classified according to pre-pandemic, period of pandemic, and COVID-19 status from July 2019.
Antibiotic-resistant infections killed about 12 million people worldwide in 2019 and is expected to increase tenfold by 2050. The COVID-19 epidemic raises several questions about the appropriate use and management of antibiotics, and research is emerging that the epidemic is also related to AMR secondary infection.
The increase in the use of antibiotics to treat COVID-19 patients and the medical system for infection prevention and control are also affecting the AMR rate. The research team emphasized the importance of long-term AMR monitoring by infectious diseases.
Reporter Jang Bom-i [email protected]
Copyrightⓒ ‘Honest knowledge for health’ Comedy.com (https://kormedi.com) / Unauthorized reproduction-redistribution prohibited
Source: 코메디닷컴 by kormedi.com.
*The article has been translated based on the content of 코메디닷컴 by kormedi.com. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!